Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Zhongguo yao li xue bao = Acta pharmacologica Sinica

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 10375753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Huperzine A, a novel promising acetylcholinesterase inhibitor

  1996cited by this paper
• Huperzine A (shuangyiping): a promising drug for Alzheimer's disease.

  1996cited by this paper
• Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.

  1994cited by this paper
• Acute and chronic studies with the anticholinesterase Huperzine A: effect on central nervous system cholinergic parameters.

  1991cited by this paper
• Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.

  1989cited by this paper
• Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

  1986cited by this paper
• Oral physostigmine treatment of patients with Alzheimer's disease.

  1985cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Predicting cerebral acetylcholine dynamics with huperzine A pharmacokinetics in blood via mPBPK-PD modeling.

  2026cites this paper
• Huperzine A: a natural acetylcholinesterase inhibitor with multifunctional neuroprotective effects

  2025cites this paper
• Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights.

  2024cites this paper
• The apoptotic effect of the Lycopodium clavatum extracts on MCF-7 human breast cancer cells

  2023cites this paper
• Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.

  2023cites this paper
• The promising role of natural products in Alzheimer's disease

  2022cites this paper
• Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review

  2022cites this paper
• Natural products as bioactive agents in the prevention of dementia.

  2022cites this paper
• Mechanistic Insight into the Binding of Huperzine a with Human Transferrin: Computational, Spectroscopic and Calorimetric Approaches

  2022cites this paper
• Medicinal pteridophytes: ethnopharmacological, phytochemical, and clinical attributes

  2022cites this paper
• Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches

  2022cites this paper
• The traditional uses, secondary metabolites, and pharmacology of Lycopodium species

  2021cites this paper
• Alkaloid quantitation and chemical fingerprinting of Icelandic Huperzia selago genotypes using HPLC-UV and UPLC-QToF-MS

  2020cites this paper
• Huperzin A: Gölgede Kalmış Bir Nootropik Ajan

  2019cites this paper
• A REVIEW ON RECENT UPDATES OF ACETYLCHOLINESTERASE INHIBITORS FROM PLANT SOURCES

  2018cites this paper
• Intranasal delivery of a novel acetylcholinesterase inhibitor HLS‐3 for treatment of Alzheimer's disease

  2018cites this paper
• Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity

  2017cites this paper
• Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques

  2017cites this paper
• Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview

  2016cites this paper
• An efficient route to bicycle[3.3.1] intermediate employing organocatalytic Michael/Aldol biannulation: a formal synthesis of (+)-Huperzine A

  2016cites this paper
• Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology

  2016influential citation
• Safety and efficacy of Lycopodium clavatum 200dH in Toxoplasma gondii infected mice

  2016cites this paper
• Plant alkaloids as drug leads for Alzheimer's disease.

  2015cites this paper
• Ferns and Lycopods—A Potential Treasury of Anticancer Agents but Also a Carcinogenic Hazard

  2014cites this paper
• Acetylcholine Elevation Relieves Cognitive Rigidity and Social Deficiency in a Mouse Model of Autism

  2014cites this paper
• A review study on medicinal plants used in the treatment of learning and memory impairments

  2014cites this paper
• Botanics: a potential source of new therapies for Alzheimer's disease?

  2014cites this paper
• Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.

  2013cites this paper
• Huperzine A, but not tacrine, stimulates S100B secretion in astrocyte cultures.

  2013cites this paper
• Lycopodine triggers apoptosis by modulating 5-lipoxygenase, and depolarizing mitochondrial membrane potential in androgen sensitive and refractory prostate cancer cells without modulating p53 activity: signaling cascade and drug-DNA interaction.

  2013cites this paper
• Huperzine A: An Update on the Psychopharmacology of a Putative Disease-Modifying Alkaloid of Interest in Alzheimer’s Disease and Other Neurological Conditions

  2013cites this paper
• Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases

  2013cites this paper
• Lycopodium Alkaloids: Pharmacology

  2013cites this paper
• Pharmacogenetics: Would it be a Reason for the Lack of Potency and Intrinsic Toxicity of Several Natural Medicines?

  2012cites this paper
• Decreased Accumulation of Subcellular Amyloid-β with Improved Mitochondrial Function Mediates the Neuroprotective Effect of Huperzine A

  2012cites this paper
• Natural polyphenols against neurodegenerative disorders: potentials and pitfalls.

  2012cites this paper
• The pharmacology and therapeutic potential of (−)-huperzine A

  2012influential citation
• Journal of Complementary and Integrative Medicine Pharmacology of Huperzine A , an Alkaloid Isolated from Huperzine Serrata , a Novel Cognition Enhancer with Dual Cholinergic and NMDA Action . Implications in Schizophrenia and Dementia

  2011cites this paper
• Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation.

  2010cites this paper
• Systemic administration of the potential countermeasure huperzine reversibly inhibits central and peripheral acetylcholinesterase activity without adverse cognitive-behavioral effects.

  2010cites this paper
• SYNTHESIS OF THE BICYCLO[3.3.1]NONANE CORE OF HUPERZINE A AND NOVEL PYRIDINE-FUSED TRICYCLES BY CYCLISATION OF PYRIDINE-BASED RADICALS

  2009cites this paper
• Huperzine A from Huperzia species--an ethnopharmacolgical review.

  2007cites this paper
• Treating senile dementia with traditional Chinese medicine

  2007cites this paper
• Complete 1H NMR spectral fingerprint of huperzine A

  2007cites this paper
• Pharmacological Profile of Huperzine A, a Novel Acetylcholinesterase Inhibitor from Chinese Herb

  2006influential citation
• Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor

  2006cites this paper
• Molecular lipophilicity determination of a huperzine series by HPLC: comparison of C18 and IAM stationary phases.

  2006cites this paper
• Iptakalim alleviated the increase of extracellular dopamine and glutamate induced by 1-methyl-4-phenylpyridinium ion in rat striatum.

  2006cites this paper
• Lead compounds and drug candidates from some Turkish plants for human health

  2006cites this paper
• The regulation of rotenone-induced inflammatory factor production by ATP-sensitive potassium channel expressed in BV-2 cells.

  2006cites this paper
• Effect of oral administration of zanapezil (TAK‐147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats

  2005cites this paper
• Preparation andin vivo evaluation of huperzine A-loaded PLGA microspheres

  2005cites this paper
• Neuroprotective Herbs for Stroke Therapy In Traditional Eastern Medicine

  2005cites this paper
• Acetylcholinesterase Inhibitors from Natural Resources

  2005cites this paper
• Neuroprotective Effects of Huperzine A

  2005cites this paper
• The Lycopodium alkaloids.

  2004cites this paper
• Recent pharmacological studies on natural products in China.

  2004cites this paper
• The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.

  2003cites this paper
• Dietary Supplements

  2003cites this paper
• Medicinal Chemistry Of Bioactive Natural Products

  2003cites this paper
• A palladium-catalyzed synthetic approach to new Huperzine A analogues modified at the pyridone ring

  2003cites this paper
• Acute effects of huperzine A and tacrine on rat liver.

  2003cites this paper
• Effects of huperzine A on liver cytochrome P-450 in rats.

  2003cites this paper
• Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats.

  2002cites this paper
• Herbal and nonherbal supplements in medical-psychiatric patient populations.

  2002cites this paper
• Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147.

  2002cites this paper
• Huperzine A.

  2000cites this paper
• Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.

  2000cites this paper
• Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.

  1999cites this paper
• Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine.

  1998cites this paper
• IR spectrum and normal mode analysis of the antiAlzheimer's disease natural product Huperzine A: A quantum chemistry density-functional theory (DFT) investigation

  1998cites this paper